| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Rate, Fetal | 9 | 2022 | 51 | 4.160 |
Why?
|
| Cesarean Section | 16 | 2022 | 367 | 2.790 |
Why?
|
| Embolism, Amniotic Fluid | 5 | 2020 | 25 | 2.650 |
Why?
|
| Hypertension, Pregnancy-Induced | 5 | 2022 | 72 | 2.450 |
Why?
|
| Pregnancy | 59 | 2022 | 7573 | 2.370 |
Why?
|
| Pregnancy Complications | 7 | 2020 | 526 | 2.290 |
Why?
|
| Maternal Mortality | 9 | 2020 | 77 | 2.150 |
Why?
|
| Pregnancy Complications, Cardiovascular | 4 | 2019 | 99 | 2.150 |
Why?
|
| Pre-Eclampsia | 4 | 2022 | 212 | 2.030 |
Why?
|
| Obstetric Labor Complications | 4 | 2018 | 95 | 1.720 |
Why?
|
| Venous Thromboembolism | 4 | 2019 | 335 | 1.670 |
Why?
|
| Placenta Accreta | 10 | 2022 | 122 | 1.660 |
Why?
|
| Labor, Obstetric | 4 | 2021 | 86 | 1.570 |
Why?
|
| Obstetrics | 6 | 2019 | 221 | 1.430 |
Why?
|
| Delivery, Obstetric | 6 | 2020 | 227 | 1.390 |
Why?
|
| Cardiotocography | 3 | 2021 | 16 | 1.380 |
Why?
|
| Fetal Monitoring | 3 | 2022 | 50 | 1.240 |
Why?
|
| Prenatal Care | 4 | 2020 | 325 | 1.110 |
Why?
|
| Reproductive Techniques, Assisted | 2 | 2017 | 101 | 1.100 |
Why?
|
| Gynecology | 3 | 2017 | 217 | 1.080 |
Why?
|
| Postpartum Hemorrhage | 5 | 2019 | 81 | 0.970 |
Why?
|
| Apgar Score | 2 | 2021 | 55 | 0.930 |
Why?
|
| Umbilical Arteries | 1 | 2021 | 59 | 0.800 |
Why?
|
| Healthcare Disparities | 2 | 2017 | 598 | 0.780 |
Why?
|
| Placenta Previa | 5 | 2022 | 61 | 0.770 |
Why?
|
| Radiologic Health | 1 | 2020 | 2 | 0.760 |
Why?
|
| Brachial Plexus | 1 | 2021 | 45 | 0.760 |
Why?
|
| Extraction, Obstetrical | 2 | 2016 | 7 | 0.730 |
Why?
|
| Acidosis | 2 | 2021 | 116 | 0.720 |
Why?
|
| Clinical Decision-Making | 3 | 2018 | 524 | 0.710 |
Why?
|
| Female | 60 | 2022 | 141928 | 0.690 |
Why?
|
| Abortion, Spontaneous | 1 | 2020 | 112 | 0.670 |
Why?
|
| Antisepsis | 1 | 2018 | 12 | 0.670 |
Why?
|
| Shock | 1 | 2020 | 88 | 0.660 |
Why?
|
| Povidone-Iodine | 1 | 2018 | 21 | 0.660 |
Why?
|
| Surgical Procedures, Operative | 2 | 2020 | 383 | 0.650 |
Why?
|
| Hysterectomy | 7 | 2022 | 611 | 0.640 |
Why?
|
| Premature Birth | 2 | 2020 | 407 | 0.640 |
Why?
|
| Chlorhexidine | 1 | 2018 | 88 | 0.630 |
Why?
|
| Liability, Legal | 1 | 2018 | 48 | 0.630 |
Why?
|
| Women's Health Services | 1 | 2017 | 16 | 0.610 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2018 | 121 | 0.610 |
Why?
|
| Thymus Neoplasms | 1 | 2022 | 400 | 0.590 |
Why?
|
| Professional Staff Committees | 1 | 2016 | 30 | 0.590 |
Why?
|
| Infant, Newborn | 12 | 2022 | 8223 | 0.590 |
Why?
|
| Maternal-Child Health Services | 1 | 2016 | 14 | 0.590 |
Why?
|
| Obstetrical Forceps | 1 | 2016 | 8 | 0.580 |
Why?
|
| Maternal Death | 1 | 2016 | 9 | 0.580 |
Why?
|
| Birth Certificates | 1 | 2016 | 24 | 0.570 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2016 | 90 | 0.570 |
Why?
|
| Ethanol | 1 | 2018 | 264 | 0.570 |
Why?
|
| Peer Review | 1 | 2016 | 80 | 0.560 |
Why?
|
| Patient Safety | 3 | 2016 | 649 | 0.560 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2016 | 66 | 0.560 |
Why?
|
| Perinatal Care | 1 | 2016 | 63 | 0.550 |
Why?
|
| Infertility, Female | 1 | 2017 | 217 | 0.540 |
Why?
|
| Postnatal Care | 1 | 2015 | 47 | 0.540 |
Why?
|
| Patient Care Bundles | 1 | 2015 | 30 | 0.530 |
Why?
|
| Hospitals | 1 | 2019 | 485 | 0.530 |
Why?
|
| Intermittent Pneumatic Compression Devices | 1 | 2015 | 11 | 0.520 |
Why?
|
| Humans | 63 | 2022 | 261506 | 0.510 |
Why?
|
| Education, Nursing | 1 | 2015 | 18 | 0.510 |
Why?
|
| Oxytocics | 1 | 2014 | 27 | 0.510 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 450 | 0.500 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2015 | 69 | 0.500 |
Why?
|
| Labor, Induced | 1 | 2014 | 34 | 0.500 |
Why?
|
| Oxytocin | 1 | 2014 | 62 | 0.500 |
Why?
|
| Anticoagulants | 2 | 2019 | 787 | 0.490 |
Why?
|
| Hospitalists | 1 | 2015 | 57 | 0.490 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2016 | 186 | 0.490 |
Why?
|
| Pregnancy Outcome | 6 | 2021 | 643 | 0.480 |
Why?
|
| Simulation Training | 1 | 2016 | 149 | 0.480 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2017 | 419 | 0.480 |
Why?
|
| Research Design | 2 | 2018 | 1544 | 0.480 |
Why?
|
| Hypoxia | 1 | 2016 | 443 | 0.470 |
Why?
|
| Hypertension | 1 | 2022 | 1503 | 0.450 |
Why?
|
| Algorithms | 4 | 2017 | 3890 | 0.450 |
Why?
|
| beta-Lactamases | 1 | 2015 | 179 | 0.440 |
Why?
|
| Escherichia coli Infections | 1 | 2015 | 241 | 0.430 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 1162 | 0.420 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2015 | 418 | 0.410 |
Why?
|
| Guideline Adherence | 1 | 2016 | 636 | 0.410 |
Why?
|
| Maternal Age | 4 | 2020 | 152 | 0.400 |
Why?
|
| United States | 13 | 2020 | 15433 | 0.380 |
Why?
|
| Patient Compliance | 1 | 2015 | 667 | 0.370 |
Why?
|
| Blood Gas Analysis | 2 | 2021 | 100 | 0.370 |
Why?
|
| Blood Loss, Surgical | 4 | 2019 | 309 | 0.370 |
Why?
|
| Gestational Age | 7 | 2022 | 1069 | 0.360 |
Why?
|
| Placenta Diseases | 2 | 2022 | 56 | 0.360 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 748 | 0.360 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 1303 | 0.350 |
Why?
|
| Quality Improvement | 1 | 2016 | 851 | 0.340 |
Why?
|
| Biomedical Research | 1 | 2016 | 806 | 0.330 |
Why?
|
| Blood Coagulation Disorders | 2 | 2021 | 120 | 0.330 |
Why?
|
| Fetal Death | 2 | 2018 | 113 | 0.320 |
Why?
|
| Stillbirth | 2 | 2018 | 82 | 0.320 |
Why?
|
| Blood Component Transfusion | 4 | 2021 | 89 | 0.310 |
Why?
|
| Placenta | 5 | 2022 | 516 | 0.310 |
Why?
|
| Intraoperative Complications | 2 | 2021 | 301 | 0.300 |
Why?
|
| Postoperative Complications | 3 | 2019 | 5542 | 0.290 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 1697 | 0.270 |
Why?
|
| Risk Factors | 10 | 2020 | 17523 | 0.270 |
Why?
|
| Prenatal Diagnosis | 3 | 2021 | 590 | 0.270 |
Why?
|
| Practice Guidelines as Topic | 4 | 2016 | 2403 | 0.270 |
Why?
|
| Adult | 23 | 2021 | 77950 | 0.250 |
Why?
|
| Evidence-Based Medicine | 2 | 2022 | 1085 | 0.250 |
Why?
|
| Registries | 3 | 2020 | 2170 | 0.220 |
Why?
|
| Pregnancy Trimesters | 2 | 2021 | 36 | 0.210 |
Why?
|
| Labor Presentation | 1 | 2021 | 9 | 0.210 |
Why?
|
| Labor Stage, Second | 1 | 2021 | 15 | 0.200 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 4971 | 0.200 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2021 | 830 | 0.200 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2021 | 29 | 0.190 |
Why?
|
| Urologic Diseases | 1 | 2021 | 78 | 0.190 |
Why?
|
| Perineum | 2 | 2021 | 107 | 0.190 |
Why?
|
| Nifedipine | 1 | 2020 | 25 | 0.190 |
Why?
|
| Labetalol | 1 | 2020 | 12 | 0.190 |
Why?
|
| Patient Selection | 2 | 2020 | 2055 | 0.190 |
Why?
|
| Retrospective Studies | 16 | 2022 | 37905 | 0.180 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2021 | 119 | 0.180 |
Why?
|
| Erythrocyte Transfusion | 2 | 2019 | 212 | 0.180 |
Why?
|
| Risk Adjustment | 1 | 2020 | 83 | 0.180 |
Why?
|
| Vasa Previa | 1 | 2019 | 6 | 0.180 |
Why?
|
| Blood Coagulation | 1 | 2021 | 185 | 0.180 |
Why?
|
| Remission, Spontaneous | 1 | 2019 | 119 | 0.170 |
Why?
|
| Fetal Hemoglobin | 1 | 2019 | 33 | 0.170 |
Why?
|
| Hospital Administration | 1 | 2019 | 29 | 0.170 |
Why?
|
| Uterine Hemorrhage | 1 | 2019 | 59 | 0.170 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2019 | 47 | 0.170 |
Why?
|
| Bicarbonates | 1 | 2019 | 130 | 0.170 |
Why?
|
| Obstetric Labor, Premature | 1 | 2019 | 80 | 0.170 |
Why?
|
| Fertilization in Vitro | 1 | 2020 | 199 | 0.160 |
Why?
|
| Administration, Cutaneous | 1 | 2018 | 141 | 0.160 |
Why?
|
| Patient Care Team | 3 | 2019 | 795 | 0.160 |
Why?
|
| Cohort Studies | 5 | 2022 | 9244 | 0.160 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2019 | 585 | 0.160 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2018 | 28 | 0.160 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 4744 | 0.160 |
Why?
|
| Fetal Mortality | 1 | 2017 | 8 | 0.150 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 144 | 0.150 |
Why?
|
| Episiotomy | 1 | 2017 | 17 | 0.150 |
Why?
|
| Blood Transfusion | 1 | 2021 | 583 | 0.150 |
Why?
|
| Antihypertensive Agents | 1 | 2020 | 395 | 0.150 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2016 | 14 | 0.150 |
Why?
|
| Learning Curve | 1 | 2017 | 68 | 0.150 |
Why?
|
| Peripartum Period | 1 | 2016 | 35 | 0.140 |
Why?
|
| Oxygen | 1 | 2021 | 754 | 0.140 |
Why?
|
| Birth Rate | 1 | 2016 | 17 | 0.140 |
Why?
|
| Drug Combinations | 1 | 2018 | 621 | 0.140 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 4314 | 0.140 |
Why?
|
| Nomograms | 1 | 2019 | 313 | 0.140 |
Why?
|
| Epidemics | 1 | 2017 | 63 | 0.140 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 383 | 0.140 |
Why?
|
| Infusions, Intravenous | 2 | 2020 | 1382 | 0.140 |
Why?
|
| Fetal Distress | 1 | 2016 | 9 | 0.140 |
Why?
|
| Maternal-Fetal Relations | 1 | 2016 | 14 | 0.140 |
Why?
|
| Health Status Indicators | 1 | 2017 | 224 | 0.140 |
Why?
|
| Parturition | 1 | 2016 | 65 | 0.140 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2017 | 87 | 0.140 |
Why?
|
| New York | 1 | 2015 | 104 | 0.140 |
Why?
|
| Fetal Blood | 1 | 2019 | 482 | 0.140 |
Why?
|
| Risk Assessment | 3 | 2020 | 6869 | 0.130 |
Why?
|
| Bradycardia | 1 | 2016 | 70 | 0.130 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 260 | 0.130 |
Why?
|
| Infant Mortality | 1 | 2016 | 186 | 0.130 |
Why?
|
| Benchmarking | 1 | 2017 | 273 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 280 | 0.130 |
Why?
|
| Young Adult | 6 | 2020 | 21445 | 0.130 |
Why?
|
| Reproduction | 1 | 2017 | 253 | 0.130 |
Why?
|
| Zika Virus Infection | 1 | 2017 | 166 | 0.120 |
Why?
|
| Pneumothorax | 1 | 2016 | 153 | 0.120 |
Why?
|
| Congresses as Topic | 1 | 2016 | 298 | 0.120 |
Why?
|
| Cephalosporins | 1 | 2015 | 148 | 0.120 |
Why?
|
| Checklist | 1 | 2014 | 122 | 0.120 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 348 | 0.120 |
Why?
|
| Incidence | 2 | 2022 | 5673 | 0.110 |
Why?
|
| Time Factors | 2 | 2018 | 12926 | 0.110 |
Why?
|
| Patient Admission | 1 | 2014 | 220 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2019 | 6100 | 0.110 |
Why?
|
| Birth Weight | 3 | 2022 | 374 | 0.110 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 225 | 0.110 |
Why?
|
| Clinical Protocols | 1 | 2015 | 467 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2015 | 414 | 0.110 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2014 | 273 | 0.110 |
Why?
|
| Hospital Mortality | 1 | 2018 | 1274 | 0.110 |
Why?
|
| Consensus | 1 | 2016 | 978 | 0.110 |
Why?
|
| Prospective Studies | 5 | 2021 | 12873 | 0.110 |
Why?
|
| Preoperative Care | 1 | 2018 | 1529 | 0.100 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2015 | 994 | 0.100 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 329 | 0.100 |
Why?
|
| Thrombocytopenia | 1 | 2016 | 846 | 0.100 |
Why?
|
| Disease Management | 1 | 2016 | 1052 | 0.100 |
Why?
|
| Urinary Tract Infections | 1 | 2015 | 321 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 622 | 0.090 |
Why?
|
| Referral and Consultation | 1 | 2015 | 899 | 0.090 |
Why?
|
| Decision Making | 1 | 2017 | 1287 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2016 | 1270 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2017 | 1375 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 3719 | 0.070 |
Why?
|
| Logistic Models | 2 | 2019 | 3441 | 0.050 |
Why?
|
| Infant | 1 | 2016 | 13310 | 0.050 |
Why?
|
| Blood Coagulation Tests | 1 | 2021 | 87 | 0.050 |
Why?
|
| Causality | 1 | 2020 | 178 | 0.050 |
Why?
|
| Pelvis | 1 | 2022 | 362 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2020 | 111 | 0.050 |
Why?
|
| Thrombelastography | 1 | 2021 | 79 | 0.050 |
Why?
|
| Hemoglobin A | 1 | 2019 | 34 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2018 | 32848 | 0.040 |
Why?
|
| Acid-Base Imbalance | 1 | 2019 | 30 | 0.040 |
Why?
|
| Acid-Base Equilibrium | 1 | 2019 | 78 | 0.040 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2019 | 106 | 0.040 |
Why?
|
| Platelet Transfusion | 1 | 2019 | 156 | 0.040 |
Why?
|
| Live Birth | 1 | 2018 | 56 | 0.040 |
Why?
|
| Plasma | 1 | 2019 | 158 | 0.040 |
Why?
|
| Placenta, Retained | 1 | 2017 | 13 | 0.040 |
Why?
|
| Texas | 2 | 2020 | 6311 | 0.040 |
Why?
|
| Fetus | 1 | 2021 | 601 | 0.040 |
Why?
|
| Isotonic Solutions | 1 | 2017 | 46 | 0.040 |
Why?
|
| Inservice Training | 1 | 2017 | 78 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2017 | 209 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 471 | 0.040 |
Why?
|
| Breech Presentation | 1 | 2016 | 22 | 0.040 |
Why?
|
| Gravidity | 1 | 2016 | 19 | 0.040 |
Why?
|
| Population | 1 | 2016 | 27 | 0.040 |
Why?
|
| Middle Aged | 3 | 2020 | 86204 | 0.040 |
Why?
|
| Parity | 1 | 2017 | 139 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 672 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2021 | 712 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 1544 | 0.030 |
Why?
|
| Emergencies | 1 | 2017 | 202 | 0.030 |
Why?
|
| ROC Curve | 1 | 2019 | 1183 | 0.030 |
Why?
|
| Pregnancy, Twin | 1 | 2016 | 118 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 124 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2020 | 2316 | 0.030 |
Why?
|
| Hypotension | 1 | 2016 | 210 | 0.030 |
Why?
|
| Microcephaly | 1 | 2017 | 325 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 2218 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 4298 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 502 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2020 | 929 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2017 | 621 | 0.030 |
Why?
|
| Prognosis | 2 | 2019 | 21713 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 6009 | 0.020 |
Why?
|
| Adolescent | 2 | 2020 | 31252 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 4320 | 0.020 |
Why?
|
| Child | 1 | 2022 | 29154 | 0.010 |
Why?
|
| Male | 1 | 2020 | 123000 | 0.010 |
Why?
|